Excellence in life sciences executive search

current opportunity

The Chase Group Retained to Identify Pulmonary and Rare Disease Clinical Development Leader for Arcturus Therapeutics

October 23, 2020 biotech, clinical development, current opportunity, executive search, life sciences, mRNA, pharmaceutical, pulmonary, rare disease

The combination of expertise and passion to build transformative, life-changing medicines for patients and their families positions Arcturus Therapeutics to catalyze the next generation of… Continue Reading →

Our Client's Testimonials

The team has integrated beautifully and have already had multiple engagements with field leadership. Respect and credibility has been earned. Attitude and energy is positive…

The Chase Group team goes out of their way to make sure that they understand what we need. We are a very specialized company, they…

The Chase Group is professional, knowledgeable and effective.

The Chase Group is nimble, objective and incredibly well connected. They were able to move quickly and had fast communication which is an advantage.

I always find Chase to be forthright about their network and capabilities. Ultimately, they delivered for us, which is why I come back to them.

We were seeking to hire leadership talent, people who have technical expertise who have worked well with others, have led people, and are inspirational and…

The Chase Group team is an extension of who we are as a company. We have a very easy, open and transparent relationship. I wish…

The Chase Group team is professional, responsive and proactive. They have a keen ability to connect with people that helps them understand our business needs…

What are 3 adjectives that describe The Chase Group? Tenacious, Honest and Trust

We ended up with a good candidate pool. All of the candidates were very high caliber. We were looking for a breadth and depth of…

View More Testimonials

current opportunity

The Chase Group Retained to Identify Pulmonary and Rare Disease Clinical Development Leader for Arcturus Therapeutics

Let’s get the conversation started.